Aparna Ahuja - 06 Jan 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Medical Officer
Signature
/s/ John Sprague, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
06 Jan 2022
Net transactions value
-$29,754
Form type
4
Filing time
10 Jan 2022, 15:19:12 UTC
Previous filing
06 Jan 2022
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Sale $29,754 -61,988 -37% $0.4800 107,611 06 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 5, 2022.